Europe Deepens Investment in Israeli Tech Sector
Translated & summarized from Maariv by baba
European investors committed $4.33 billion to Israeli high-tech in the first half of 2026, with exits to European buyers exceeding $5 billion. This trend precedes the Europe Days conference in Tel Aviv, aimed at fostering further investment and collaboration. Direct European investment in Israel rose 20% in 2025, reaching $1.404 billion. The data suggests Europe is becoming a key strategic financial partner for Israel's tech sector.
The story in 6 lines · by baba
- European investors poured $4.33 billion into Israeli tech in H1 2026.
- Exits to European buyers surpassed $5 billion in 2025.
- Direct European investment in Israel grew 20% to $1.404 billion in 2025.
- The Europe Days conference will convene over 30 European representatives in Tel Aviv.
- Swiss investors are increasingly making earlier-stage investments in Israeli startups.
- Acquisitions span cybersecurity, DefenseTech, digital health, and fintech sectors.
European investors are significantly increasing their engagement with Israel's high-tech industry, injecting $4.33 billion across 66 funding rounds in the first half of 2026. This surge is complemented by a substantial rise in exits, with European acquirers purchasing Israeli companies for over $5 billion. These trends are highlighted ahead of the upcoming Europe Days conference in Tel Aviv, where over 30 European representatives will meet with Israeli tech firms to explore investment and collaboration opportunities.
Data indicates a sharp increase in acquisitions. According to IVC, the value of exits to European buyers grew from $361 million in 2020 to $5.155 billion in 2025, with nine additional such acquisitions recorded between January and August 2026. Direct European investment in Israel also saw a notable rise of approximately 20% in 2025, reaching $1.404 billion from $1.169 billion in 2024, marking the first increase since 2021.
Swiss investors, in particular, are adopting a strategy of earlier-stage investments, with a median investment of $20 million. Eight Swiss investors have deployed capital across nine separate deals this year, including the $2.4 billion acquisition of 89bio by Roche. "The aggregate picture indicates Europe's growing establishment as a strategic financial partner for Israeli high-tech," stated Tzgal. He further noted that these figures reflect the integration of Israeli technologies driven by long-term industrial needs, evident in acquisitions within cybersecurity, DefenseTech, digital health, digitization, enterprise software, and fintech, as well as increased European involvement in pilot programs and collaborations with Israeli startups.
Mentioned
